Eternity Healthcare has signed a letter of intent with PharmaNova. The contract has been signed to develop new branded pharmaceuticals. The partnership is aimed at the development of a new generation of steroids and steroids related pharmaceuticals for rapid subcutaneous absorption.

According to the terms of the contract, both firms will equally share the financing of the product development and the revenue.